IRONWOOD PHARMACEUTICALS INC (IRWD): Nasdaq/NYSE listing notice — Ironwood receives Nasdaq deficiency notice for bid price below $1.00; has until Nov 24, 2025 to regain compliance

IRONWOOD PHARMACEUTICALS INC

Received deficiency letter on May 28, 2025 for bid price below $1.00 for 30 consecutive business days.
Compliance period of 180 calendar days, until November 24, 2025, to regain minimum bid price.
To cure, bid price must close at $1.00 or more for at least 10 consecutive business days.
If not compliant by deadline, company may qualify for additional 180 days by moving to Nasdaq Capital Market.
No immediate effect on listing; company monitoring options but cannot assure compliance.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

IRONWOOD PHARMACEUTICALS INC received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5450(a)(1), 5810(c)(3)(A)

Exact text from the filing

the last 30 consecutive business days, the bid price for the Company’s Class A common stock, par value $0.001 per share (the “Common Stock”) had closed below the $1.00 per share minimum bid price requirement for continued inclusion on the Nasdaq Global Select Market pursuant to Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”). The deficiency letter has no immediate effect on the listing of the Company’s securities on Nasdaq. In accordance with Nasdaq Listing Rule 5810(c)(3)(A) (the “Compliance Period Rule”), the Company has been provided a period of 180 calendar days, or u

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

IRONWOOD PHARMACEUTICALS INC filing history →

Source: SEC EDGAR

accession 0001104659-25-055958

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.